RU94012304A - Agent for hepatitis a and b treatment
- Google Patents
Agent for hepatitis a and b treatment
Info
Publication number
RU94012304A
RU94012304ARU94012304/14ARU94012304ARU94012304ARU 94012304 ARU94012304 ARU 94012304ARU 94012304/14 ARU94012304/14 ARU 94012304/14ARU 94012304 ARU94012304 ARU 94012304ARU 94012304 ARU94012304 ARU 94012304A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Р.А. Султанов, Uz]filedCriticalР.А. Султанов
Priority to RU9494012304ApriorityCriticalpatent/RU2063230C1/en
Application grantedgrantedCritical
Publication of RU2063230C1publicationCriticalpatent/RU2063230C1/en
Publication of RU94012304ApublicationCriticalpatent/RU94012304A/en
Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Medicinal Preparation
(AREA)
Abstract
FIELD: medicine, pharmacy. SUBSTANCE: agent has the following components, mg: potassium dihydrogen phosphate, 5.5; sodium hydrogen phosphate, 40.0; sodium hydrocarbonate, 40.0; sodium chloride, 4.0; copper dichloride, 5.5; and boric acid, 5.0. Preparation normalizes acid-alkaline balance and does not exhibit by-side action. EFFECT: enhanced effectiveness of agent.
Claims (1)
Изобретение относится к медицине, а именно к созданию лекарственных средств для лечения гепатита А и В. Сущность изобретения состоит в том, что предложенное средство содержит, мг: калий фосфорно-кислый однозамещенный 5,5; натрий фосфорно-кислый двузамещенный 40,4; натрий бикарбонат 40,0; поваренная соль 4,0; двухлористая медь 5,5; борная кислота 5,0. Предложенный препарат восстанавливает и нормализует кислотно-щелочной баланс, не имеет побочных эффектов.The invention relates to medicine, namely to the creation of drugs for the treatment of hepatitis A and B. The essence of the invention lies in the fact that the proposed tool contains, mg: potassium phosphoric acid monosubstituted 5.5; sodium phosphoric acid disubstituted 40.4; sodium bicarbonate 40.0; sodium chloride 4.0; copper chloride 5.5; boric acid 5.0. The proposed drug restores and normalizes the acid-base balance, has no side effects.
RU9494012304A1994-04-071994-04-07Agent for hepatitis a and b treatment
RU2063230C1
(en)
Pharmaceutical composition for prophylaxis and treatment of viral diseases, method of its preparing and use of bradykinin antagonist or its physiologically tolerant salt as agent for prophylaxis and treatment of viral diseases